Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0105 | 0.0278 | 0.0105 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Schistosoma mansoni | hypothetical protein | 0.0105 | 0.0278 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Leishmania major | hypothetical protein, conserved | 0.0539 | 0.334 | 1 |
Brugia malayi | Sugar transporter family protein | 0.0105 | 0.0278 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0103 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.1486 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0103 | 0.0271 | 1 |
Schistosoma mansoni | glucose transport protein | 0.0105 | 0.0278 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0103 | 0.0271 | 0.5 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0105 | 0.0278 | 0.0105 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0103 | 0.0271 | 0.0098 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0103 | 0.0271 | 0.0098 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0103 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Schistosoma mansoni | glucose transport protein | 0.0105 | 0.0278 | 1 |
Giardia lamblia | GTOR | 0.0103 | 0.0271 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0103 | 0.0271 | 0.9728 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0103 | 0.0271 | 0.0098 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0105 | 0.0278 | 0.0105 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0103 | 0.0271 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Echinococcus multilocularis | solute carrier family 2, facilitated glucose | 0.0105 | 0.0278 | 0.0105 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Echinococcus multilocularis | solute carrier family 2 facilitated glucose | 0.0105 | 0.0278 | 0.0105 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0105 | 0.0278 | 0.0105 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0105 | 0.0278 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0103 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Toxoplasma gondii | facilitative glucose transporter GT1 | 0.0105 | 0.0278 | 1 |
Plasmodium falciparum | hexose transporter | 0.0105 | 0.0278 | 0.5 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0105 | 0.0278 | 0.0105 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Loa Loa (eye worm) | sugar transporter | 0.0105 | 0.0278 | 1 |
Plasmodium vivax | hexose transporter | 0.0105 | 0.0278 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.052 | 0.32 | 1 |
Echinococcus granulosus | solute carrier family 2 facilitated glucose | 0.0105 | 0.0278 | 0.0105 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Schistosoma mansoni | glucose transport protein | 0.0105 | 0.0278 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0103 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0103 | 0.0271 | 0.0098 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0103 | 0.0271 | 0.9728 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0103 | 0.0271 | 0.9728 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.